Asarfi Hospital Limited
BBSE:ASARFI179.50
INR
-2.45
(-1.35%)
Asarfi Hospital Limited
BSE:ASARFI
(Bombay Stock Exchange)
Recent
price
179.50
P/E
ratio
25.20
div
yld
- -
ROIC.AI
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.- Similar Companies
- Business
- Asarfi Hospital Ltd (ASARFI.BO) operates a 250-bedded private super multi-specialty hospital in Dhanbad, Jharkhand, India, providing comprehensive inpatient and outpatient healthcare services including super specialty departments such as neurosciences, cardiology, obstetrics and gynaecology, neonatology and paediatrics, urology, orthopaedics, gastroenterology, burn and plastic surgery, and oncology; secondary care specialties encompassing general medicine, general surgery, pulmonology, nephrology, ENT, ophthalmology, dentistry, and emergency care; diagnostic services featuring advanced laboratory testing (NABL accredited), open X-ray, ultrasound, CT scan, endoscopy, and a world-class cardiac unit with Phillips FD10 flat panel CATHLAB; critical care facilities including CCU, ICU, NICU, SICU, high dependency unit, and labour room; and primary health services such as vaccination centres, drug distribution, health camps, hygiene awareness programs, health education centres, yoga and exercise centres, and health resorts, primarily serving patients in Jharkhand and neighbouring areas with empanelments under Government of Jharkhand schemes, East Central Railway, Coal India Limited, and various TPAs. Founded in 2005 and headquartered at Baramuri, B Polytechnic, Dhanbad, Jharkhand, the company, promoted by Nayan Prakash Singh and Harendra Singh, is NABH accredited for entry-level hospital programs and focuses on affordable, innovative healthcare bridging gaps in regional access. Recent developments include the operational launch of its 50-bed Asarfi Cancer Institute in Ranguni, Dhanbad, on 9.55 acres leased from Jharkhand Industrial Area Development Authority in Q1 2025 with an additional 50 beds in progress; a successful BSE SME IPO in 2023 raising Rs 26.94 crore at a 90% premium; plans to expand combined bed capacity from around 300 to 500 by FY26 across facilities including a potential 100-bed hospital acquisition under due diligence, introduction of an IVF vertical, bone marrow transplant unit in the cancer hospital, and a new Health Management and Research Institute in Ranchi at Rs 40 crore project cost targeted for FY28 operations; and a strategic partnership formed on May 19, 2025, with Gleneagles Hospital, Chennai.